Israel Englander Allovir, Inc. Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Allovir, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 3,295,729 shares of ALVR stock, worth $3.33 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,295,729
Previous 2,942,608
12.0%
Holding current value
$3.33 Million
Previous $2.24 Million
6.08%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ALVR
# of Institutions
72Shares Held
46.5MCall Options Held
201KPut Options Held
3.1K-
Eco R1 Capital, LLC San Francisco, CA11.3MShares$11.4 Million0.29% of portfolio
-
Octagon Capital Advisors LP New York, NY9.8MShares$9.9 Million1.63% of portfolio
-
Artal Group S.A. Luxembourg, N46.6MShares$6.66 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.65MShares$2.67 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA1.91MShares$1.93 Million0.09% of portfolio
About Allovir, Inc.
- Ticker ALVR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,063,400
- Market Cap $94M
- Description
- Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...